Identification of transcription factors for drug-associated gene modules and biomedical implications

Bioinformatics

Volumn 30, Issue 3, 2014, Pages 305-309

  Xiong, Min ^a   Li, Bin ^a   Zhu, Qiang ^a   Wang, Yun Xing ^a   Zhang, Hong Yu ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; POLYPHENOL; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NF E2;

ARTICLE; CELL LINE; CLUSTER ANALYSIS; DRUG EFFECT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC TRANSCRIPTION; HUMAN; LIPID METABOLISM; METABOLISM; PROTEIN ANALYSIS;

CELL LINE; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HUMANS; LIPID METABOLISM; NF-E2 TRANSCRIPTION FACTOR; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; POLYPHENOLS; PROTEIN INTERACTION MAPPING; RECEPTORS, ESTROGEN; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84893328088     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btt683     Document Type: Article

References (28)

1. Abiko, Y., et al. (2011) Participation of covalent modification of Keap1 in the activation of Nrf2 by tert-butylbenzoquinone, an electrophilic metabolite of butylated hydroxyanisole. Toxicol. Appl. Pharmacol., 255, 32-39.
2. Franceschini, A., et al. (2013) STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res., 41, D808-D815.
3. Fullwood, M.J., et al. (2009) An oestrogen-receptor-alpha-bound human chromatin interactome. Nature, 462, 58-64.
4. Gil-Izquierdo, A., et al. (2012) Soy isoflavones and cardiovascular disease epidemiological, clinical and -omics perspectives. Curr. Pharm. Biotechnol., 13, 624-631.
5. Gu, J. and Liu, J.S. (2008) Bayesian biclustering of gene expression data. BMC Genomics, 9 (Suppl 1) , S4.
6. Halliwell, B., et al. (2005) Health promotion by flavonoids, tocopherols, tocotrienols, and other phenols: direct or indirect effects? Antioxidant or not? Am. J. Clin. Nutr., 81, 268S-276S.
7. Hochreiter, S., et al. (2010) FABIA: factor analysis for bicluster acquisition. Bioinformatics, 26, 1520-1527.
8. Huang, D.W., et al. (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc., 4, 44-57.
9. Huang, J., et al. (2013) Systematic prediction of pharmacodynamic drug-drug interactions through protein-protein-interaction network. PLoS Comput. Biol., 9, e1002998.
10. Iorio, F., et al. (2010) Discovery of drug mode of action and drug repositioning from transcriptional responses. Proc. Natl Acad. Sci. USA, 107, 14621-14626.
11. Iskar, M., et al. (2013) Characterization of drug-induced transcriptional modules: towards drug repositioning and functional understanding. Mol. Syst. Biol., 9, 662.
12. Kaidery, N.A., et al. (2013) Targeting Nrf2-mediated gene transcription by extremely potent synthetic triterpenoids attenuate dopaminergic neurotoxicity in the MPTP mouse model of Parkinsons disease. Antioxid Redox Signal., 18, 139-157.
13. Kuiper, G.G., et al. (1998) Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology, 139, 4252-4263.
14. Lamb, J., et al. (2006) The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science, 313, 1929-1935.
15. Li, G., et al. (2012) Extensive promoter-centered chromatin interactions provide a topological basis for transcription regulation. Cell, 148, 84-98.
16. Messina, M., et al. (2009) Report on the 8th International Symposium on the Role of Soy in Health Promotion and Chronic Disease Prevention and Treatment. J. Nutr., 139, 796S-802S.
17. OLeary, K.A., et al. (2004) Effect of flavonoids and vitamin E on cyclooxygenase-2 (COX-2) transcription. Mutat Res., 551, 245-254.
18. Okoh, V.O., et al. (2013) Reactive oxygen species via redox signaling to PI3K/AKT pathway contribute to the malignant growth of 4-hydroxy estradiol-transformed mammary epithelial cells. PLoS One, 8, e54206.
19. Sandhu, K.S., et al. (2012) Large-scale functional organization of long-range chromatin interaction networks. Cell Rep., 2, 1207-1219.
20. Suthram, S., et al. (2010) Network-based elucidation of human disease similarities reveals common functional modules enriched for pluripotent drug targets. PLoS Comput. Biol., 6, e1000662.
21. Tham, D.M., et al. (1998) Clinical review 97: Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. J. Clin. Endocrinol. Metab., 83, 2223-2235.
22. Theocharis, S., et al. (2004) Peroxisome proliferator-activated receptor-gamma ligands as cell-cycle modulators. Cancer Treat. Rev., 30, 545-554.
23. Villa, A., et al. (2012) Tetradian oscillation of estrogen receptor alpha is necessary to prevent liver lipid deposition. Proc. Natl Acad. Sci. USA, 109, 11806-11811.
24. Wishart, D.S. (2008) DrugBank and its relevance to pharmacogenomics. Pharmacogenomics, 9, 1155-1162.
25. Yu, C.Y., et al. (2010) Genome-wide analysis of glucocorticoid receptor binding regions in adipocytes reveal gene network involved in triglyceride homeostasis. PLoS One, 5, e15188.
26. Zhang, H.Y., et al. (2010) Evolutionary inspirations for drug discovery. Trends Pharmacol. Sci., 31, 443-448.
27. Zhang, T., et al. (2013) Activation of nuclear factor erythroid 2-related factor 2 and PPARgamma plays a role in the genistein-mediated attenuation of oxidative stress-induced endothelial cell injury. Br. J. Nutr., 109, 223-235.
28. Zhu, F., et al. (2012) Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery. Nucleic Acids Res., 40, D1128-D1136.